Connect with others who understand.

  • Learn from expert-reviewed resources
  • Real advice from people who’ve been there
  • People who understand what you’re going through
Sign Up Log In
Powered By
Real members of MyMyelomaTeam have posted questions and answers that support our community guidelines, and should not be taken as medical advice. Looking for the latest medically reviewed content by doctors and experts? Visit our resource section.
A MyMyelomaTeam Member asked a question 💭
Galena, MD

Who is Ben on a clinical trial and if so, are you a minority?

June 4, 2023
 · 
Reactions
A MyMyelomaTeam Member

Daratumumab

June 22, 2024
A MyMyelomaTeam Member

I was on Faratumamab alone about 4 - 5 years ago. It was the first drug in half a decade to get me into a sustained remission!

June 22, 2024
A MyMyelomaTeam Member

Hello Mr. Mike,
I am on Cycle 3 of S1803, Phase III study of Daratumumab/rHuPH20 + Lenalidomide or Lenalidomide only as Post ASCT for Maintenance. I am on the Lenalidomide only group. I am not a minority. My next follow up is June 15th
Larry 5

June 7, 2023
A MyMyelomaTeam Member

Congratulations on being in a clinical trial. How are things going health wise?

June 4, 2023
A MyMyelomaTeam Member

I am in the Revlimid and dexamethasone study and have completed the medication portion. My first clinical follow up is June 6, 2023.

June 4, 2023

Related Questions

View All
A MyMyelomaTeam Member asked a question 💭
West Des Moines, IA

A MyMyelomaTeam Member asked a question 💭
Kerala, India